Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1997
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatoninP Lissoni, G Tancini, S Barni, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
Minerva Medica|June 30, 1985
[Daily secretion of parathyroid hormone in adult subjects]R Mauri, M Resentini, P Lissoni, et al.
American Journal of Surgery|April 1, 1991
Effect of antitumor surgery on soluble interleukin-2 receptor serum levelsF Brivio, P Lissoni, D Mancini, et al.
Giornale Italiano Di Cardiologia|October 1, 1991
[Cardioangioimmunology: the immune implications in the principle cardiovascular pathologies]P Lissoni, S Barni, O Mauri, et al.
The International Journal of Biological Markers|April 1, 1988
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratioS Barni, P Lissoni, S Crispino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Changes in T lymphocyte subsets after single dose epirubicinP Lissoni, G Tancini, C Archili, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1997
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatoninP Lissoni, G Tancini, S Barni, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
Minerva Medica|June 30, 1985
[Daily secretion of parathyroid hormone in adult subjects]R Mauri, M Resentini, P Lissoni, et al.
American Journal of Surgery|April 1, 1991
Effect of antitumor surgery on soluble interleukin-2 receptor serum levelsF Brivio, P Lissoni, D Mancini, et al.
Giornale Italiano Di Cardiologia|October 1, 1991
[Cardioangioimmunology: the immune implications in the principle cardiovascular pathologies]P Lissoni, S Barni, O Mauri, et al.
The International Journal of Biological Markers|April 1, 1988
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratioS Barni, P Lissoni, S Crispino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Changes in T lymphocyte subsets after single dose epirubicinP Lissoni, G Tancini, C Archili, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
Pageof 29